KRRO Korro Bio Inc.
Price (delayed)
$40.44
Market cap
$376.04M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$15.42
Enterprise value
$321.59M
frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the
Highlights
KRRO's quick ratio has surged by 122% year-on-year
KRRO's EPS has soared by 95% YoY and by 80% QoQ
KRRO's net income has dropped by 82% year-on-year and by 4.7% since the previous quarter
Korro Bio's debt has increased by 38% YoY and by 7% from the previous quarter
Key stats
What are the main financial stats of KRRO
Market
Valuations
Earnings
Shares outstanding
9.3M
Market cap
$376.04M
Enterprise value
$321.59M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.89
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$91.59M
EBITDA
-$83.34M
Free cash flow
-$100.54M
Per share
Balance sheet
Liquidity
EPS
-$15.42
Free cash flow per share
-$11.19
Book value per share
$21.36
Revenue per share
$0
TBVPS
$27.77
Total assets
$249.59M
Total liabilities
$51.51M
Debt
$38.46M
Equity
$198.08M
Working capital
$151.3M
Debt to equity
0.19
Current ratio
13.28
Quick ratio
12.92
Net debt/EBITDA
0.65
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-51.5%
Return on equity
-66.3%
Return on invested capital
-113.3%
Return on capital employed
-38.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KRRO stock price
How has the Korro Bio stock price performed over time
Intraday
-2.48%
1 week
-5.36%
1 month
12.43%
1 year
88.01%
YTD
-15.63%
QTD
19.4%
Financial performance
How have Korro Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$97.77M
Net income
-$92.22M
Gross margin
N/A
Net margin
N/A
KRRO's operating income has dropped by 85% year-on-year and by 6% since the previous quarter
KRRO's net income has dropped by 82% year-on-year and by 4.7% since the previous quarter
Growth
What is Korro Bio's growth rate over time
Valuation
What is Korro Bio stock price valuation
P/E
N/A
P/B
1.89
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
KRRO's EPS has soared by 95% YoY and by 80% QoQ
Korro Bio's equity has increased by 31% from the previous quarter
The stock's price to book (P/B) is 12% less than its 5-year quarterly average of 2.2 and 12% less than its last 4 quarters average of 2.2
Efficiency
How efficient is Korro Bio business performance
The return on equity has surged by 73% year-on-year and by 24% since the previous quarter
KRRO's ROIC has plunged by 57% YoY but it is up by 36% from the previous quarter
KRRO's return on assets is up by 20% since the previous quarter
Dividends
What is KRRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KRRO.
Financial health
How did Korro Bio financials performed over time
The current ratio has soared by 129% YoY
KRRO's quick ratio has surged by 122% year-on-year
Korro Bio's debt is 81% less than its equity
KRRO's debt to equity has dropped by 69% year-on-year and by 21% since the previous quarter
Korro Bio's debt has increased by 38% YoY and by 7% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.